A Japanese drugmaker, Kobayashi Pharmaceutical, has reported two more deaths potentially related to its dietary supplements containing red yeast rice. Last week, the company recalled three supplement brands due to customer complaints of kidney problems. The total number of deaths being investigated is now four, with over 100 others hospitalized. Red yeast rice is known to help lower cholesterol but can also pose a risk of organ damage. The government is taking steps to ensure food safety, ordering health-food makers to review their products. The company has also supplied red yeast rice to other firms in Japan and Taiwan, prompting recalls of various products.
Source link
Japan drugmaker reports two more deaths in supplement scare
